A new review of data for Roche's flu drug Tamiflu has concluded the drug does not reduce hospitalisations and serious complications of the virus – and that it leads to harmful effects in patients.

Apart from Xofluza, Roche has another flu drug, named Tamiflu, in its portfolio. Roche’s year-to-date performance has been impressive on high demand for its drugs and tests. Vabysmo (eye ...

Roche has reported a positive start to 2013 ... as did the severe flu season in North America which led to an 84% higher demand in Tamiflu. Sales in the pharmaceuticals division rose by 7% ...

Engineering microbes could be our best hope for creating enough antiviral drugs. As fears spread about a potential flu pandemic, Roche's antiviral drug Tamiflu (oseltamivir phosphate) has found ...

ZURICH (Reuters) - Swiss drugmaker Rochehas launched a programme to ease access to its antiviral drug Tamiflu for developing countries, the group said on Wednesday. The programme should ensure ...

Data from the drugmaker, Shionogi, show that while Xofluza works days faster than Tamiflu in stopping the flu virus, symptoms wrap up in about the same timeframe for either medication. Roche, which ...

Tamiflu is already available in nine countries, including Switzerland, the United States, Canada, and several in Latin America. The drug has become one of Roche’s best-selling products ...

The anti flu treatment medicine acclaimed the world over Tamiflu now will be made in India. The licence has been given by Swiss firm Roche to make a generic version of its anti-flu treatment ...

The government’s dilemma is whether to import Tamiflu in large quantities from Roche or to license a domestic generic manufacturer to make it here at a tenth of the price and stock it.